CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259. Published online 2018 January 2 DOI: https://doi.org/10.4143/crt.2017.438

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park

Cancer Research and Treatment. 2018;50(4):1252-1259

Link1

Link2 Link3

Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer

Robert J. Amato, L. Michael Glode, Jeremy Podolnick, Robert Knight, David Crawford

Cancers. 2011;3(3):3449-3460

Link1

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

T M Beer, D C Smith, A Hussain, M Alonso, J Wang, M Giurescu, K Roth, Y Wang

British Journal of Cancer. 2012;107(5):808-813

Link1

Link2 Link3

Castration Resistant Prostate Cancer: Role of Chemotherapy

Marijo Bilusic

Prostate Cancer. 2016;509-514

Link1 Link2

Options After Chemotherapy for Patients with Metastatic, Castration-Resistant Prostate Cancer

Daniel J. Lee, Neal D. Shore

Prostate Cancer. 2018;121-134

Link1

Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill, Philippe Beuzeboc

BJU International. 2010;106(7):974-978

Link1

Emerging treatment options for patients with castration-resistant prostate cancer

Daniel George, Judd W. Moul

The Prostate. 2011;72(3):338-349

Link1

Re: [177Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study

Kathia De Man, Piet Ost

European Urology. 2018;

Link1 Link2

Editorial Comment on: A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

Henk G. van der Poel

European Urology. 2009;56(1):103-104

Link1 Link2

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh

The Prostate. 2011;72(8):834-845

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.